Paris – September 19, 2026 -- Virbac posted first-half 2026 revenue growth of 7.4% at constant exchange rates and currencies (CERS), lifting its adjusted EBIT margin to 18.8%, up 0.5 percentage points from H1 2025.

Companion animal segment leads growth at 10.0%, farm animal follows at 6.7%

The animal health group's Supercharge platforms, excluding Thyronorm, expanded around 12% at CERS, becoming a key driver of top-line performance. Growth split into a volume/mix effect of approximately 5.4% and a price increase of roughly 2%.

London – September 19, 2026 -- UK biotech spin-out Eterna Regeneratives has closed a seed funding round led by Hoxton Ventures and The Venture Collective to commercialize a keratin-based material that regrows tooth enamel, targeting the $43 billion global oral care market.

New York – September 19, 2026 -- DarioHealth Corp. (NASDAQ: DRIO) has secured a new contract with one of New Jersey's largest health plans, covering approximately 1.5 million lives, through its channel partnership with Amwell. The program covering Dario's cardiometabolic suite and provider-backed care is expected to launch and begin generating revenue in the first quarter of 2027.

Provo, Utah – September 19, 2026 -- Canary Speech has been named to TIME and Statista's World's Top HealthTech Companies 2026 ranking, marking the second consecutive year the vocal biomarker technology firm has received the distinction.

TIME and Statista select 500 companies from thousands of HealthTech firms reviewed globally

The ranking evaluated companies across three primary data sources: Financial Performance Metrics, Reputation Analysis, and Online Engagement. The list was announced on September 17, 2026, and published on Time.com.

Aurora, Colo. – September 19, 2026 -- A new study from the University of Colorado Anschutz Marcus Institute for Brain Health finds that irritability following chronic mild traumatic brain injury (mTBI) in military veterans stems from a combination of PTSD symptoms, chronic pain and difficulty understanding speech in noisy environments, not a single psychological cause.

Shanghai – September 19, 2026 -- 111, Inc. (NASDAQ: YI) reported a net loss of RMB31.7 million (US$4.7 million) for the second quarter of 2026, more than four times the RMB7.3 million loss posted a year earlier, as the Shanghai-based healthcare platform accelerated its shift away from an asset-heavy distribution model.

Geneva – September 19, 2026 -- MindMaze Therapeutics (SIX: MMTX) will launch MindMotion Lite by the end of 2026, a tablet-based neurorehabilitation device designed to cut home deployment costs and expand access to intensive stroke and neurological therapy outside clinical settings.

Sheridan, Wyo. – September 19, 2026 -- The global diagnostic imaging market will expand from $26.5 billion in 2026 to $33.2 billion by 2031, a 4.6% compound annual growth rate, according to a new study by Wissen Research.

Washington – September 18, 2026 -- More than 20,100 Americans signed a petition in just four days demanding Congress reauthorize the Accelerating Access to Critical Therapies (ACT) for ALS law before its September 30, 2026 expiration date.

Washington – September 18, 2026 -- First Health Advisory has launched Resilience360, a consulting program designed to validate whether hospitals and health systems can keep clinical operations running during cyberattacks, technology outages, third-party failures, and natural disasters.